We sought to evaluate antimicrobial use among patients with advanced cancer.
Methods:
Retrospective review of patients experiencing cancer-related death while hospitalized.
Results:
Among 145 patients, 126 (86.9%) received antimicrobials for a mean of 12.5 ± 12.9 days. 88 (69.8%) of 126 had clinical findings suggestive of infection. Sixty-one patients (48.4%) had positive cultures, the remaining were treated empirically. “Comfort care” was ultimately pursued in 99 (78.5%) of 126; 35 (35.4%) of 99 continued to receive antimicrobials after a transition to comfort care for an average of 1.6 ± 1.1 days. On average, antimicrobials were discontinued <1day prior to death.
Conclusion:
Antimicrobial use was common among patients with advanced cancer. Even after transition to comfort care, more than one third of patients remained on antimicrobials. The risks and burdens of antimicrobials should be carefully examined when comfort is the stated goal.
WhitePHKuhlenschmidtHLVancuraBGNavariRM. Antimicrobial use in patients with advanced cancer receiving hospice care. J Pain Symptom Manage. 2003;25(5):438–443.
2.
OneschukDFainsingerRDemoissacD. Antibiotic use in the last week of life in three different palliative care settings. J Palliat Care. 2002;18(1):25–28.
3.
PereiraJWatanabeSWolchG. A retrospective review of the frequency of infections and patterns of antibiotic utilization on a palliative care unit. J Pain Symptom Manage. 1998;16(6):374–381.
4.
MarcusELClarfieldAMMosesAE. Ethical issues relating to the use of antimicrobial therapy in older adults. Clin Infect Dis. 2001;33(10):1697–1705.
5.
LamPTChanKSTseCYLeungMW. Retrospective analysis of antibiotic use and survival in advanced cancer patients with infections. J Pain Symptom Manage. 2005;30(6):536–543.
6.
OhDYKimJHKimDW. Antibiotic use during the last days of life in cancer patients. Eur J Cancer Care. 2006;15(1):74–79.
7.
Al-ShaqiMAHasan AlamiAAl- ZahraniAS. The pattern of antimicrobial use for palliative care in-patients during the last week of life. Am J Hosp Palliat Care. 2011. doi:10.1177/1049909111406900.
8.
FordPJFraserTGDavisMPKodishE. Anti-infective therapy at the end of life: ethical decision-making in hospice-eligible patients. Bioethics. 2005;19(4):379–392.
9.
AschDAFaber-LangendoenKSheaJAChristakisNA. The sequence of withdrawing life-sustaining treatment from patients. Am J Med. 1999; 107(2):153–156.
10.
ChunEDRodgersPEVitaleCACollinsCDMalaniPN. Antimicrobial use among patients receiving palliative care consultation. Am J Hosp Palliat Care. 2010 ;27(4):261–265.
D’AgataEMitchellSL. Patterns of antimicrobial use among nursing home residents with advanced dementia. Arch Intern Med. 2008;168(4):357–362.
13.
HomsiJWalshDPantaR. Infectious complications of advanced cancer. Support Care Cancer. 2000;8:487–492.
14.
ClaytonJFardellBHutton-PottsJWebbDChyeR. Parenteral antibiotics in a palliative care unit: prospective analysis of current practice. Palliat Med. 2003;17(1):44–48.
15.
Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep. 1995;44:1–13.
16.
RybakMLomaestroBRotschaferJC. Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66(1):82–98.
17.
MirhosseiniMOneschukDHunterB. The role of antibiotics in the management of infection-related symptoms in advanced cancer patients. J Palliat Care. 2006;22(2):69–74.
18.
van der SteenJTOomsMEvan der WalGRibbeMW. Pneumonia: the demented patient’s best friend? Discomfort after starting or withholding antibiotic treatment. J Am Geriatr Soc. 2002;50(10):1681–1688.
19.
GivensJLJonesRNShafferMLKielyDKMitchellSL. Survival and comfort after treatment of pneumonia in advanced dementia. Arch Intern Med. 2010;170(13):1102–1107.
20.
JenningsADaviesAHigginsJGibbsJBroadleyK. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57(11):939–944.
21.
JenningsALDaviesANHigginsJPBroadleyK. Opioids for the palliation of breathlessness in terminal illness. Cochrane Database Syst Rev. 2001;(4): CD002066.
22.
StielSKrummNPestingerM. Antibiotics in palliative medicine—results from a prospective epidemiological investigation from the HOPE survey. Support Care Cancer. 2011. dOI:10.1007/s00520-011-1084-1
23.
LevinPDSimorAEMosesAESprungCL. End-of-life treatment and bacterial antibiotic resistance: a potential association. Chest. 2010;138(3):588–594.
24.
NiedermanMSBergerJT. The delivery of futile care is harmful to other patients. Crit Care Med. 2010;38(10 suppl): S518–S522.
